SPEAKERS

Abbas Walji

Senior Director, Discovery Chemistry

Merck

Cameron Pye

Chief Executive Officer

Unnatural Products

Christian Cunningham

Chief Scientific Officer

PeptiDream Inc.

David Brayden

Full Professor, Advanced Drug Delivery

University College Dublin

Dehua Pei

Professor

Ohio State University

Emel Adaligil

Principal Scientific Manager

Genentech

James Bowman

Director - Protein Engineering

AI Proteins

Jeffrey Schubert

Principal Scientist

Merck

John Tan

Director, Informatics

Nimble Therapeutics

Joshua Schwochert

Co-founder & Chief Scientific Officer

Unnatural Products

Laura Nevola

Co-Founder, Chief Scientific Officer & Chief Operating Officer

IDP Pharma

Lauren Goodrich-Berto

Vice President - Therapeutic Discovery

Nimble Therapeutics

Mah Kheirabadi

Director - Discovery Chemistry

Entrada Therapeutics Inc.

Manuel Sanchez-Felix

Vice President Drug Delivery Search & Evaluation

Halozyme Therapeutics

Markus Haeberlein

Vice President - Discovery Science Executive

Parabilis Medicines

Meritxell Teixido

CEO and Co-founder

Gate2Brain S.L.

Miriam Kidron

CSO

Oramed Pharmaceuticals

Patrick Salveson

Co-Founder & Chief Technology Officer

Vilya

Pete Gough

Chief Scientific Officer

Nimble Therapeutics

Ranganath Gopalakrishnan

Director, New Modalities Medicinal Chemistry, Early CVRM

AstraZeneca

Rick EWING

VP, Head of Chemistry

Rapafusyn Pharmaceuticals

Robert Maguire

Director of Chemistry

Cybrexa Therapeutics

Sevan Habeshian

Co-founder & Chief Technology Officer

Orbis Medicines

Thomas Von Erlach

Co-Founder & Chief Scientific Officer

Vivtex

Tina Boville

Chief Executive Officer & Co-Founder

Aralez Bio

Toby Passioura

Chief Scientific Officer

Insamo

Tomi Sawyer

Chief Drug Hunter & President

Maestro Therapeutics

Xavier Michelet

Director of Biology, Head of pharmacology

AI Proteins

Yoshihisa Murata

Head of Advanced Computational Chemistry Group

Chugai Pharmaceutical Co

Yu-Shan Lin

Professor and Department Chair of Chemistry

Tufts University